Overview
Neoplasm of gastrointestinal tract is a disorder.
Auto-generated from clinical reference data. Not a substitute for medical advice.
Treatments & Interventions
Doxorubicin hydrochloride
substance
Imatinib mesylate
substance
Doxorubicin
substance
Trastuzumab
substance
Daunorubicin hydrochloride liposome
substance
Trastuzumab emtansine
substance
Lutetium (177-Lu) oxodotreotide
substance
Doxorubicin hydrochloride pegylated liposome
substance
Lutetium (177-Lu) dotatate
substance
Trastuzumab deruxtecan
substance
Related Conditions
Neoplasm of intestinal tract(child)
Benign neoplasm of gastrointestinal tract(child)
Carcinoma in situ of gastrointestinal tract(child)
Neoplasm of uncertain behavior of gastrointestinal tract(child)
Gastrointestinal anastomotic tumor recurrence(child)
Submucosal tumor of gastrointestinal tract(child)
Gastrointestinal eosinophilic granuloma(child)
Tumor of esophagus, stomach and duodenum(child)
Malignant neoplasm of gastrointestinal tract(child)
Neoplasm of anus(child)
Disorder of gastrointestinal tract(parent)
Neoplasm of digestive tract(parent)
Quick Facts
- SNOMED CT
- 126768004
- UMLS CUI
- C0017185
- Fully Specified Name
- Neoplasm of gastrointestinal tract (disorder)
- Specialists
- 0
- Diagnostic Biomarkers
- 0
- Known Treatments
- 10
Medical Disclaimer
This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.
Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.